author_facet Smith MD, Kathleen J.
Skelton MD, Henry G.
Ruiz MD, Nancy
Samlaska MD, Kurt
Wagner MD, Kenneth F.
Smith MD, Kathleen J.
Skelton MD, Henry G.
Ruiz MD, Nancy
Samlaska MD, Kurt
Wagner MD, Kenneth F.
author Smith MD, Kathleen J.
Skelton MD, Henry G.
Ruiz MD, Nancy
Samlaska MD, Kurt
Wagner MD, Kenneth F.
spellingShingle Smith MD, Kathleen J.
Skelton MD, Henry G.
Ruiz MD, Nancy
Samlaska MD, Kurt
Wagner MD, Kenneth F.
International Journal of Dermatology
Cutaneous reactions at the site of post‐infection gp160 vaccination therapy in HIV‐1+ patients
Dermatology
author_sort smith md, kathleen j.
spelling Smith MD, Kathleen J. Skelton MD, Henry G. Ruiz MD, Nancy Samlaska MD, Kurt Wagner MD, Kenneth F. 0011-9059 1365-4632 Wiley Dermatology http://dx.doi.org/10.1046/j.1365-4362.1998.00272.x <jats:p> <jats:italic>Background</jats:italic> Post‐infection vaccination with human immunodeficiency virus type 1</jats:p><jats:p>(HIV‐1) specific antigens has been hypothesized as a mechanism for generating a more effective immune response to the HIV‐1 virus. Cutaneous reactions at the site of immunization may provide information on the pattern of immune activation induced by the vaccine.</jats:p><jats:p> <jats:italic>Objective</jats:italic> To evaluate exaggerated local cutaneous reactions in eight HIV‐1+ patients enrolled in a phase I and II gp160 vaccine study.</jats:p><jats:p> <jats:italic>Methods</jats:italic> Cutaneous biopsy specimens were obtained and evaluated using routine histologic, immunofluorescence, and immunohistochemical techniques.</jats:p><jats:p> <jats:italic>Results</jats:italic> A mononuclear cell infiltrate with tissue eosinophilia, in some cases forming flame figures, was present on histologic sections. There was no evidence of immune complex deposition. Activated T‐helper cells formed a major portion of the mononuclear cell infiltrate.</jats:p><jats:p> <jats:italic>Conclusions</jats:italic> A delayed‐type hypersensitivity reaction, mediated by T cells with a T‐helper 2 cytokine pattern, was favored by clinical and histologic features. The most likely antigen stimulating this reaction is residual lepidopteran used in the preparation of the vaccine; however, baculovirus antigens may also play a role. In addition, the adjuvant, aluminum phosphate, as well as the underlying patterns of immune dysregulation present in HIV‐1+ patients, may potentiate these reactions.</jats:p> Cutaneous reactions at the site of post‐infection gp160 vaccination therapy in HIV‐1+ patients International Journal of Dermatology
doi_str_mv 10.1046/j.1365-4362.1998.00272.x
facet_avail Online
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA0Ni9qLjEzNjUtNDM2Mi4xOTk4LjAwMjcyLng
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA0Ni9qLjEzNjUtNDM2Mi4xOTk4LjAwMjcyLng
institution DE-D275
DE-Bn3
DE-Brt1
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
imprint Wiley, 1998
imprint_str_mv Wiley, 1998
issn 0011-9059
1365-4632
issn_str_mv 0011-9059
1365-4632
language English
mega_collection Wiley (CrossRef)
match_str smithmd1998cutaneousreactionsatthesiteofpostinfectiongp160vaccinationtherapyinhiv1patients
publishDateSort 1998
publisher Wiley
recordtype ai
record_format ai
series International Journal of Dermatology
source_id 49
title Cutaneous reactions at the site of post‐infection gp160 vaccination therapy in HIV‐1+ patients
title_unstemmed Cutaneous reactions at the site of post‐infection gp160 vaccination therapy in HIV‐1+ patients
title_full Cutaneous reactions at the site of post‐infection gp160 vaccination therapy in HIV‐1+ patients
title_fullStr Cutaneous reactions at the site of post‐infection gp160 vaccination therapy in HIV‐1+ patients
title_full_unstemmed Cutaneous reactions at the site of post‐infection gp160 vaccination therapy in HIV‐1+ patients
title_short Cutaneous reactions at the site of post‐infection gp160 vaccination therapy in HIV‐1+ patients
title_sort cutaneous reactions at the site of post‐infection gp160 vaccination therapy in hiv‐1+ patients
topic Dermatology
url http://dx.doi.org/10.1046/j.1365-4362.1998.00272.x
publishDate 1998
physical 293-298
description <jats:p> <jats:italic>Background</jats:italic> Post‐infection vaccination with human immunodeficiency virus type 1</jats:p><jats:p>(HIV‐1) specific antigens has been hypothesized as a mechanism for generating a more effective immune response to the HIV‐1 virus. Cutaneous reactions at the site of immunization may provide information on the pattern of immune activation induced by the vaccine.</jats:p><jats:p> <jats:italic>Objective</jats:italic> To evaluate exaggerated local cutaneous reactions in eight HIV‐1+ patients enrolled in a phase I and II gp160 vaccine study.</jats:p><jats:p> <jats:italic>Methods</jats:italic> Cutaneous biopsy specimens were obtained and evaluated using routine histologic, immunofluorescence, and immunohistochemical techniques.</jats:p><jats:p> <jats:italic>Results</jats:italic> A mononuclear cell infiltrate with tissue eosinophilia, in some cases forming flame figures, was present on histologic sections. There was no evidence of immune complex deposition. Activated T‐helper cells formed a major portion of the mononuclear cell infiltrate.</jats:p><jats:p> <jats:italic>Conclusions</jats:italic> A delayed‐type hypersensitivity reaction, mediated by T cells with a T‐helper 2 cytokine pattern, was favored by clinical and histologic features. The most likely antigen stimulating this reaction is residual lepidopteran used in the preparation of the vaccine; however, baculovirus antigens may also play a role. In addition, the adjuvant, aluminum phosphate, as well as the underlying patterns of immune dysregulation present in HIV‐1+ patients, may potentiate these reactions.</jats:p>
container_issue 4
container_start_page 293
container_title International Journal of Dermatology
container_volume 37
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792333811960250373
geogr_code not assigned
last_indexed 2024-03-01T14:18:42.01Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Cutaneous+reactions+at+the+site+of+post%E2%80%90infection+gp160+vaccination+therapy+in+HIV%E2%80%901%2B+patients&rft.date=1998-04-01&genre=article&issn=1365-4632&volume=37&issue=4&spage=293&epage=298&pages=293-298&jtitle=International+Journal+of+Dermatology&atitle=Cutaneous+reactions+at+the+site+of+post%E2%80%90infection+gp160+vaccination+therapy+in+HIV%E2%80%901%2B+patients&aulast=Wagner+MD&aufirst=Kenneth+F.&rft_id=info%3Adoi%2F10.1046%2Fj.1365-4362.1998.00272.x&rft.language%5B0%5D=eng
SOLR
_version_ 1792333811960250373
author Smith MD, Kathleen J., Skelton MD, Henry G., Ruiz MD, Nancy, Samlaska MD, Kurt, Wagner MD, Kenneth F.
author_facet Smith MD, Kathleen J., Skelton MD, Henry G., Ruiz MD, Nancy, Samlaska MD, Kurt, Wagner MD, Kenneth F., Smith MD, Kathleen J., Skelton MD, Henry G., Ruiz MD, Nancy, Samlaska MD, Kurt, Wagner MD, Kenneth F.
author_sort smith md, kathleen j.
container_issue 4
container_start_page 293
container_title International Journal of Dermatology
container_volume 37
description <jats:p> <jats:italic>Background</jats:italic> Post‐infection vaccination with human immunodeficiency virus type 1</jats:p><jats:p>(HIV‐1) specific antigens has been hypothesized as a mechanism for generating a more effective immune response to the HIV‐1 virus. Cutaneous reactions at the site of immunization may provide information on the pattern of immune activation induced by the vaccine.</jats:p><jats:p> <jats:italic>Objective</jats:italic> To evaluate exaggerated local cutaneous reactions in eight HIV‐1+ patients enrolled in a phase I and II gp160 vaccine study.</jats:p><jats:p> <jats:italic>Methods</jats:italic> Cutaneous biopsy specimens were obtained and evaluated using routine histologic, immunofluorescence, and immunohistochemical techniques.</jats:p><jats:p> <jats:italic>Results</jats:italic> A mononuclear cell infiltrate with tissue eosinophilia, in some cases forming flame figures, was present on histologic sections. There was no evidence of immune complex deposition. Activated T‐helper cells formed a major portion of the mononuclear cell infiltrate.</jats:p><jats:p> <jats:italic>Conclusions</jats:italic> A delayed‐type hypersensitivity reaction, mediated by T cells with a T‐helper 2 cytokine pattern, was favored by clinical and histologic features. The most likely antigen stimulating this reaction is residual lepidopteran used in the preparation of the vaccine; however, baculovirus antigens may also play a role. In addition, the adjuvant, aluminum phosphate, as well as the underlying patterns of immune dysregulation present in HIV‐1+ patients, may potentiate these reactions.</jats:p>
doi_str_mv 10.1046/j.1365-4362.1998.00272.x
facet_avail Online
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA0Ni9qLjEzNjUtNDM2Mi4xOTk4LjAwMjcyLng
imprint Wiley, 1998
imprint_str_mv Wiley, 1998
institution DE-D275, DE-Bn3, DE-Brt1, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229
issn 0011-9059, 1365-4632
issn_str_mv 0011-9059, 1365-4632
language English
last_indexed 2024-03-01T14:18:42.01Z
match_str smithmd1998cutaneousreactionsatthesiteofpostinfectiongp160vaccinationtherapyinhiv1patients
mega_collection Wiley (CrossRef)
physical 293-298
publishDate 1998
publishDateSort 1998
publisher Wiley
record_format ai
recordtype ai
series International Journal of Dermatology
source_id 49
spelling Smith MD, Kathleen J. Skelton MD, Henry G. Ruiz MD, Nancy Samlaska MD, Kurt Wagner MD, Kenneth F. 0011-9059 1365-4632 Wiley Dermatology http://dx.doi.org/10.1046/j.1365-4362.1998.00272.x <jats:p> <jats:italic>Background</jats:italic> Post‐infection vaccination with human immunodeficiency virus type 1</jats:p><jats:p>(HIV‐1) specific antigens has been hypothesized as a mechanism for generating a more effective immune response to the HIV‐1 virus. Cutaneous reactions at the site of immunization may provide information on the pattern of immune activation induced by the vaccine.</jats:p><jats:p> <jats:italic>Objective</jats:italic> To evaluate exaggerated local cutaneous reactions in eight HIV‐1+ patients enrolled in a phase I and II gp160 vaccine study.</jats:p><jats:p> <jats:italic>Methods</jats:italic> Cutaneous biopsy specimens were obtained and evaluated using routine histologic, immunofluorescence, and immunohistochemical techniques.</jats:p><jats:p> <jats:italic>Results</jats:italic> A mononuclear cell infiltrate with tissue eosinophilia, in some cases forming flame figures, was present on histologic sections. There was no evidence of immune complex deposition. Activated T‐helper cells formed a major portion of the mononuclear cell infiltrate.</jats:p><jats:p> <jats:italic>Conclusions</jats:italic> A delayed‐type hypersensitivity reaction, mediated by T cells with a T‐helper 2 cytokine pattern, was favored by clinical and histologic features. The most likely antigen stimulating this reaction is residual lepidopteran used in the preparation of the vaccine; however, baculovirus antigens may also play a role. In addition, the adjuvant, aluminum phosphate, as well as the underlying patterns of immune dysregulation present in HIV‐1+ patients, may potentiate these reactions.</jats:p> Cutaneous reactions at the site of post‐infection gp160 vaccination therapy in HIV‐1+ patients International Journal of Dermatology
spellingShingle Smith MD, Kathleen J., Skelton MD, Henry G., Ruiz MD, Nancy, Samlaska MD, Kurt, Wagner MD, Kenneth F., International Journal of Dermatology, Cutaneous reactions at the site of post‐infection gp160 vaccination therapy in HIV‐1+ patients, Dermatology
title Cutaneous reactions at the site of post‐infection gp160 vaccination therapy in HIV‐1+ patients
title_full Cutaneous reactions at the site of post‐infection gp160 vaccination therapy in HIV‐1+ patients
title_fullStr Cutaneous reactions at the site of post‐infection gp160 vaccination therapy in HIV‐1+ patients
title_full_unstemmed Cutaneous reactions at the site of post‐infection gp160 vaccination therapy in HIV‐1+ patients
title_short Cutaneous reactions at the site of post‐infection gp160 vaccination therapy in HIV‐1+ patients
title_sort cutaneous reactions at the site of post‐infection gp160 vaccination therapy in hiv‐1+ patients
title_unstemmed Cutaneous reactions at the site of post‐infection gp160 vaccination therapy in HIV‐1+ patients
topic Dermatology
url http://dx.doi.org/10.1046/j.1365-4362.1998.00272.x